Symbia
Symbia is an AI platform designed to accelerate Investigational New Drug (IND) filings for pharmaceutical companies. It automates tedious tasks such as planning, document writing, and identifying compliance issues. By uploading drug candidate profiles and nonclinical data, Symbia generates customized roadmaps for IND-enabling studies, drafts regulatory documents like CTD non-clinical modules and Investigators' Brochures, and proactively flags compliance problems. This allows users to receive comprehensive regulatory support and submit their applications months faster. Symbia's business model appears to be SaaS-based, offering a platform for regulatory document generation and study planning.
Symbia
Symbia is an AI platform designed to accelerate Investigational New Drug (IND) filings for pharmaceutical companies. It automates tedious tasks such as planning, document writing, and identifying compliance issues. By uploading drug candidate profiles and nonclinical data, Symbia generates customized roadmaps for IND-enabling studies, drafts regulatory documents like CTD non-clinical modules and Investigators' Brochures, and proactively flags compliance problems. This allows users to receive comprehensive regulatory support and submit their applications months faster. Symbia's business model appears to be SaaS-based, offering a platform for regulatory document generation and study planning.